Prevalence and incidence of depressive symptoms in pharmacy students: A systematic review

Clavero, Maryana Albino; Visacri, Marília Berlofa; Lima, Tácio de Mendonça; Rotta, Inajara; Aguiar, Patrícia Melo

doi:10.1016/j.japh.2023.06.012

Cited by 1 publication

(2 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Having a mental health condition, using psychotropic drugs, and having a relationship with someone that used any psychotropic were more common in 5th year students than in 1st years, which was expected due to the age difference and the challenges of pharmacy education over time [ 14 ]. The fact that almost one in three students has consulted a psychiatrist or psychologist at least once shows that they care about their mental health and that, as a society, we should not neglect the mental health of future pharmacists.…”

Section: Discussionmentioning

confidence: 99%

“…It is known that approximately one in four pharmacy students report clinically significant symptoms of anxiety and depression with a cumulative effect throughout the school years [ 12 , 13 ]. In a systematic review on the prevalence of depressive symptoms, severe symptoms were observed in up to 50% of pharmacy students [ 12 , 14 ]. Furthermore, this group includes health professionals such as future community, clinical, and industrial pharmacists.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Web Survey of Turkish Pharmacy Students Comparing First and Fifth Years’ Antidepressant Awareness and Stigmatizing Attitudes Regarding Depression and Anxiety

Yalçın,

Özkan,

Allegaert

et al. 2024

Pharmacy

View full text Add to dashboard Cite

The prevalence of depression and anxiety has increased day by day. Prejudice, self-stigma, and public stigma, on the other hand, continue to prevent patients from seeking adequate treatment, particularly in traditional communities. In this web-based, cross-sectional study, both the presence of depression and anxiety, and the knowledge, attitude, and awareness of first- and fifth (final)-year pharmacy students were examined via an online survey. The aim was to demonstrate the potential impact of public information and five years of pharmacy school on knowledge, attitude, and awareness. Our study population consisted of first- and fifth-year pharmacy students enrolled in one faculty of pharmacy during the spring semester of 2022–2023. The Beck Depression Inventory and Beck Anxiety Scale were utilized to measure the presence of depression and anxiety, while the Depression and Antidepressant Awareness and Knowledge Scale (DAKAS) was applied to assess their knowledge, attitude, and awareness. Fifth-year participants (n = 101) exhibited noticeably fewer stigmatizing attitudes than first-year participants (n = 104) (p < 0.05). There was no statistically significant difference between the mean Beck Depression Inventory and Beck Anxiety scores in first- and fifth-year pharmacy students. Being in the fifth class (OR: 3.690; p = 0.025), being of female gender (OR: 4.653; p < 0.001), and having a relationship with someone who took a psychotropic (OR: 3.060; p = 0.008) were associated with a lower overall stigma score by multiple linear regression analysis. The students’ awareness of antidepressants and familiarity with mental health issues at the end of their pharmacy education were higher and stigmatization behavior was lower than in first-year students. The positive attitudes at the end of their training towards depression will reduce the likelihood of future pharmacists’ patients from being exposed to stigmatization, prevents the formation of an additional stress factor, and likely will improve pharmacy practices.

show abstract

Section: Discussionmentioning

confidence: 99%